Development and Reproduction (한국발생생물학회지:발생과생식)

The Korean Society of Developmental Biology (한국발생생물학회)
권호 표지

Expressions of Norepinephrine Transporter in Pre-eclamptic Placenta

자간전증 태반에서의 Norepinephrine Transporter(NET) 발현

  • 나규환 (차의과학대학교 의생명과학과) ;
  • 이현정 (차바이오앤디오스텍 CHA 줄기세포연구소) ;
  • 정지은 (차의과학대학교 의생명과학과) ;
  • 김기진 (차의과학대학교 의생명과학과)
  • Received : 2010.03.05
  • Accepted : 2010.04.26
  • Published : 2010.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Placenta has been shown to be a site of expression of several of the monoamine membrane uptake transporters. However, the correlation between the expressions of norepinephrine transporter (NET) and placental development including gynecological diseases is still unknown. To investigate the expression and functions of NET in placenta, we conducted to compare NET expression in normal and preeclamptic placenta and analyzed the function of NET in HTR8-SV/neo trophoblast cells after NET gene transfection. The expression of NET was analyzed in placental tissues from the following groups of patients (none underwent labor): 1) term normal placenta (n=15); 2) term with preeclamptic placeneta (n=15); and 3) pre-term with preeclamptic placenta (n=11) using semi-quantitative RT-PCR, immunohistochemistry, and Western blot. In order to evaluate the function of NET, NET gene plasmid and NET gene-specific siRNA were trnasfected into HTR-8/SVneo trophoblast cells for 24 hours. NET had low expression in the pre-eclamptic placenta compare with normal placenta but no difference in western blot data. NET was expressed in the trophoblasts, and the up-regulation of NET gene stimulated the invasion of HTR-8/SVneo trophoblast cells by 2.5 fold (p<0.05), whereas the NET-siRNA treatment reduced invasion rates. Also, we observed that the expression of NET induces to expression and activity of MMP-9 in HTR-8/SVneo trophoblast cells in zymography. The results suggest that the expression of NET were reduced in pre-eclampsia and should be inhibited invasion activity of trophoblasts. Therefore, these findings provide useful guidelines for the mechanisms of trophoblast invasion as well as for the basic understanding of gynecological diseases including pre-eclampsia.

지금까지 태반에서 monoamine들을 재 흡수할 수 있는 몇 가지 membrane transporter들이 발현됨이 보고되었다. 그러나 카테콜라민 트렌스포터(norepinephrine transporter, NET)의 발현과 부인과 질환을 포함한 태반 발달과의 연관성에 관한 연구는 거의 보고된 것이 없다. 본 연구의 목적은 태반에서 NET의 발현을 동정하고, 그 기능을 알아보고자 하였다. 이를 위해 정상과 자간전증(preeclampsia) 태반에서 각각 NET 단백질을 동정하고, 영양막세포주인 HTR8-SV/neo 영양막 세포에 NET 유전자를 주입 후 그 기능을 분석하였다. NET 발현을 분석하고자 태반조직에서 다음과 같이 환자를 분류하여 semi-quantitative RT-PCR과 면역조직화학 방법을 사용하였다. 분만 고통이 없는 산모의 태반을 중심으로(none underwent labor): 1) 만기 정상 태반(term normal placenta)(n=15); 2) 만기 자간전증 태반(term with preeclamptic placenta)(n=15); 3) 중기 자간전증 태반(pre-term preeclamptic placenta)(n=11)을 수집하여, NET 발현을 RNA 수준에서 분석한 결과, mRNA 분석에서는 NET 유전자가 정상 태반 조직보다 자간전증 태반에서 낮게 발현되는 것을 확인하였다. 그러나 Western blot을 통한 NET 단백질의 변화는 거의 없는 것으로 확인되었다. HTR8-SV/neo 영양막세포를 이용하여, NET 유전자의 기능을 알아보고자 NET 유전자의 플라스미드(a plasmid vector for NET gene)와 siRNA(NET gene-specific siRNA)을 HTR8-SV/neo 영양막 세포에 24시간 동안 각각 핵 내 주입하고, NET 유전자 발현에 따른 침윤은 NET 유전자를 증가시킨 경우 대조군보다 2.5배(p<0.05) 촉진시키는 것으로 확인됐으며, NET 유전자를 감소시킨 경우는 침윤능력이 감소하는 경향이 관찰되었다. 또한 NET의 과도한 고발현 또는 저발현은 MMP-2와 MMP-9 발현과 활성을 저해하는 것이 관찰하였다. 따라서 자간전증에서 NET의 발현 감소는 영양막세포의 침윤능력을 억제하는 요인이 될 수 있다. 그러므로 이러한 결과들은 영양막세포의 침윤 기전뿐만 아니라 자간전증을 포함한 부인과 질환의 기초 연구에 지침을 제공할 것이다.

Keywords

References

  1. Anderson EA, Sinkey CA, Lawton WJ, Mark AL (1989) Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings. Hypertension 14:177-183. https://doi.org/10.1161/01.HYP.14.2.177
  2. Balkovetz DF, Tiruppathi C, Leibach FH, Mahesh VB, Ganapathy V (1989) Evidence for an imipramine-sensitive serotonin transporter in human placental brushborder membranes. J Biol Chem 264:2195-2198.
  3. Benischke K, Kaufmann P (2000) Pathology of the human placenta. New York: Springer-Verlag.
  4. Bottalico B, Larsson I, Brodszki J, Hernandez-Andrade E, Casslen B, Marsal K, Hansson SR (2004) Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies. Placenta 25:518-529. https://doi.org/10.1016/j.placenta.2003.10.017
  5. Brosens IA (1977) Morphological changes in the uteroplacental bed in pregnancy hypertension. Clin Obstet Gynaecol 4:573-593.
  6. Bzoskie L, Blount L, Kashiwai K, Tseng YT, Hay WW, Jr., Padbury JF (1995) Placental norepinephrine clearance: In vivo measurement and physiological role. Am J Physiol 269:E145-149.
  7. Cudihy D, Lee RV (2009) The pathophysiology of pre-eclampsia: Current clinical concepts. J Obstet Gynaecol 29:576-582. https://doi.org/10.1080/01443610903061751
  8. Dekker GA, Sibai BM (1998) Etiology and pathogenesis of preeclampsia: Current concepts. Am J Obstet Gynecol 179:1359-1375. https://doi.org/10.1016/S0002-9378(98)70160-7
  9. Ganapathy V, Ramamoorthy S, Leibach FH (1993) Transport and metabolism of monoamines in the human placenta. Placenta 14:35-51. https://doi.org/10.1016/S0143-4004(05)80281-4
  10. Granger JP, Alexander BT, Bennett WA, Khalil RA (2001) Pathophysiology of pregnancy-induced hypertension. Am J Hypertens 14:178S-185S. https://doi.org/10.1016/S0895-7061(01)02086-6
  11. Hayer-Zillgen M, Bruss M, Bonisch H (2002) Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3. Br J Pharmacol 136:829-836. https://doi.org/10.1038/sj.bjp.0704785
  12. Ilekis JV, Reddy UM, Roberts JM (2007) Preeclampsia--a pressing problem: an executive summary of a National Institute of Child Health and Human Development workshop. Reprod Sci 14:508-523. https://doi.org/10.1177/1933719107306232
  13. Jayanthi LD, Prasad PD, Ramamoorthy S, Mahesh VB, Leibach FH, Ganapathy V (1993) Sodium- and chloride-dependent, cocaine-sensitive, high-affinity binding of nisoxetine to the human placental norepinephrine transporter. Biochemistry 32:12178-12185. https://doi.org/10.1021/bi00096a030
  14. Jeschke U, Schiessl B, Mylonas I, Kunze S, Kuhn C, Schulze S, Friese K, Mayr D (2006) Expression of the proliferation marker Ki-67 and of p53 tumor protein in trophoblastic tissue of preeclamptic, HELLP, and intrauterine growth-restricted pregnancies. Int J Gynecol Pathol 25:354-360. https://doi.org/10.1097/01.pgp.0000225838.29127.6
  15. Klimek V, Stockmeier C, Overholser J, Meltzer HY, Kalka S, Dilley G, Ordway GA (1997) Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J Neurosci 17:8451-8458.
  16. Knofler M (2010) Critical growth factors and signalling pathways controlling human trophoblast invasion. Int J Dev Biol 54:269-280. https://doi.org/10.1387/ijdb.082769mk
  17. Manyonda IT, Slater DM, Fenske C, Hole D, Choy MY, Wilson C (1998) A role for noradrenaline in pre-eclampsia: Towards a unifying hypothesis for the pathophysiology. Br J Obstet Gynaecol 105:641-648. https://doi.org/10.1111/j.1471-0528.1998.tb10179.x
  18. Mao W, Iwai C, Qin F, Liang CS (2005) Norepinephrine induces endoplasmic reticulum stress and downregulation of norepinephrine transporter density in PC12 cells via oxidative stress. Am J Physiol Heart Circ Physiol 288:H2381-2389. https://doi.org/10.1152/ajpheart.00904.2004
  19. Mao W, Qin F, Iwai C, Vulapalli R, Keng PC, Liang CS (2004) Extracellular norepinephrine reduces neuronal uptake of norepinephrine by oxidative stress in PC12 cells. Am J Physiol Heart Circ Physiol 287:H29-39. https://doi.org/10.1152/ajpheart.01168.2003
  20. Melikian HE, Ramamoorthy S, Tate CG, Blakely RD (1996) Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recog nition. Mol Pharmacol 50:266-276.
  21. Moore KL, Persaud TVN (2008) The developing humanclinically orientated embryology. Potland (OR): Elsvier Saunders.
  22. Prasad PD, Hoffmans BJ, Moe AJ, Smith CH, Leibach FH, Ganapathy V (1996) Functional expression of the plasma membrane serotonin transporter but not the vesicular monoamine transporter in human placental trophoblasts and choriocarcinoma cells. Placenta 17:201-207. https://doi.org/10.1016/S0143-4004(96)90039-9
  23. Ramamoorthy S, Prasad PD, Kulanthaivel P, Leibach FH, Blakely RD, Ganapathy V (1993) Expression of a cocaine-sensitive norepinephrine transporter in the humanplacental syncytiotrophoblast. Biochemistry 32:1346-1353. https://doi.org/10.1021/bi00056a021
  24. Roberts JM, Cooper DW (2001) Pathogenesis and genetics of pre-eclampsia. Lancet 357:53-56. https://doi.org/10.1016/S0140-6736(00)03577-7
  25. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK (1989) Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161:1200-1204. https://doi.org/10.1016/0002-9378(89)90665-0
  26. Roberts JM, Von Versen-Hoeynck F (2007) Maternal fetal/placental interactions and abnormal pregnancy outcomes. Hypertension 49:15-16. https://doi.org/10.1161/01.HYP.0000251523.44824.02
  27. Schobel HP, Fischer T, Heuszer K, Geiger H, Schmieder RE (1996) Preeclampsia -- a state of sympathetic overactivity. N Engl J Med 335:1480-1485. https://doi.org/10.1056/NEJM199611143352002